Karen J. Ortiz-Ortiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karen J. Ortiz-Ortiz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Axel J. Gierbolini-Bermúdez
University of Puerto Rico Comprehensive Cancer Center
1 shared publication - Carlos R. Torres-Cintrón
Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
1 shared publication - Maira A. Castaneda-Avila
Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, USA
1 shared publication - Marjorie Vázquez-Roldán
University of Puerto Rico Comprehensive Cancer Center
1 shared publication - Rosa Román-Oyola
University of Puerto Rico, San Juan, Puerto Rico
1 shared publication - Tonatiuh Suárez-Ramos
University of Puerto Rico Comprehensive Cancer Center, Puerto Rico
1 shared publication
Latest Publications
- Open Access
- 7 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (5) , 676
Health Insurance and Neighborhood Deprivation as Determinants of Diagnostic Delays and Survival in Breast Cancer
Background/Objectives: Breast cancer (BC) represents a major public health problem that is influenced by social and systemic factors. This study evaluates disparities in the BC care continuum based on health insurance type and determines whether these patterns differ according to neighborhood-level deprivation. Methods: Using the Puerto Rico Central Cancer Registry-Health Insurance Linkage Database, we conducted a retrospective cohort study of women aged ≥18 years and diagnosed with BC in Puerto Rico between 2012 and 2016. The main outcomes were diagnostic delay (>60 days) and six-year mortality. Insurance type (private, Medicare, Medicaid, and dual enrollment in Medicare and Medicaid) was the main predictor, with neighborhood deprivation as a modifier. Logistic and Cox models assessed delay and survival, adjusting for key covariates. Results: Disparities in diagnostic delays and risk of death across insurance types were most evident in areas with low to average deprivation, whereas, in neighborhoods with above-average to highest deprivation, these differences diminished for diagnostic delay and disappeared for risk of death. Conclusions: These findings reveal that neighborhood environment, an intermediary social determinant of health, may affect the timeliness and quality of care provided to women diagnosed with BC.
- 7 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (5) , 676
Open AccessHealth Insurance and Neighborhood Deprivation as Determinants of Diagnostic Delays and Survival in Breast Cancer
Background/Objectives: Breast cancer (BC) represents a major public health problem that is influenced by social and systemic factors. This study evaluates disparities in the BC care continuum based on health insurance type and determines whether these patterns differ according to neighborhood-level deprivation. Methods: Using the Puerto Rico Central Cancer Registry-Health Insurance Linkage Database, we conducted a retrospective cohort study of women aged ≥18 years and diagnosed with BC in Puerto Rico between 2012 and 2016. The main outcomes were diagnostic delay (>60 days) and six-year mortality. Insurance type (private, Medicare, Medicaid, and dual enrollment in Medicare and Medicaid) was the main predictor, with neighborhood deprivation as a modifier. Logistic and Cox models assessed delay and survival, adjusting for key covariates. Results: Disparities in diagnostic delays and risk of death across insurance types were most evident in areas with low to average deprivation, whereas, in neighborhoods with above-average to highest deprivation, these differences diminished for diagnostic delay and disappeared for risk of death. Conclusions: These findings reveal that neighborhood environment, an intermediary social determinant of health, may affect the timeliness and quality of care provided to women diagnosed with BC.